Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2005; 51(2): 39-45


Allelic polymorphism of endothelialno-synthase gene and its functionalmeaning

V.E. Dosenko, V.Yu. Zagoriy, N.V. Haitovich, O.A. Gordok, O.O. Moibenko

    O.O.Bogomoletz Institute of Physiology, National Academyof Science of Ukraine, Kyiv



Abstract

Investigation of phenotypic realization of the eNOS gene al- lelic polymorphism has shown that eNOS RNA content and eNOS activity in platelets depends on genotype. Using the reverse transcription and polymerase chain reaction it was shown that eNOS mRNA content is the lowest at -786С/С promoter’s genotype. In exon 7 homozygotes (894Т/Т) the RNA level is lower than in normal homozygotes (894G/G), but it is higher than in heterozygotes (894G/T). Contrary, at intron 4 polymorphism the RNA level in the platelets from people with 4а/4а genotype is higher than in normal homozygotes and heterozygotes. Measuring of eNOS activi- ty in platelets using diaminofluorescein diacetate (DAF-2А) showed that in carriers of 786С/С promoter genotype NO- producing activity is 2.1 times lower than in normal homozygotes (Р=0.03) and 2.9 times lower comparing to hete- rozygotes (Р>0.05). еNOS activity at 894Т/Т variant of 7-th exon is also lower than in normal homozygotes (Р>0.05). Analo- gous data has been obtained while comparing eNOS activity at intron 4 polymorphism – enzyme activity was 1.7 times lower in carriers of 4а/4а genotype comparing to normal homozygotes (P>0.05) and 1.9 times lower than in heterozygotes (P>0.05). Data obtained permits to conclude, that Т-786 С polymor- phism of eNOS gene promoter effects the gene expression and eNOS activity the most significantly

References

  1. Досенко В.Є., Загорій В.Ю., Мойбенко О.О.,Пархоменко О.М. Патофізіологічні аспекти генетич-ного поліморфізму ендотеліальної NO-синтази //Фізіол. журн. – 2002. – 48. – №6. – С.86–102.
  2. Досенко В.Е., Лутай Я.М., Загорий В.Ю. и др.Частота аллельного полиморфизма гена эндотели-альной NO-синтазы у больных с острым коронар-ным синдромом в украинской популяции // Цитоло-гия и генетика. – 2005. – № 2. – С.10–18.
  3. Alderton W.K., Cooper C.E., Knowles R.G. Nitricoxide synthases: structure, function and inhibition //Biochem. J. –2001. – 357. – P.593–615.
  4. Belloc F., Hourdille P., Boisseau M.R., Bernard P. Pro-tein synthesis in human platelets correlation with plate-let size // Nouv. Rev. Fr. Hematol. – 1982. – 24, № 6. –P.369–73.
  5. Casas J.P., Bautista L.E., Humphries S.E., Hingorani A.D.Endothelial nitric oxide synthase genotype and ischemicdisease. Meta-analysis of 26 studies involving 23028subjects // Circulation. – 2004. – 109. – P.1359–1365.
  6. Cattaruzza M., Guzik T.J., Slodowski W. et al. Shearstress insensitivity of endothelial nitric oxide synthaseexpression as genetic risk factor for coronary heartdisease // Circulat. Res. – 2004. – 95. – P.841–847.
  7. Ghilardi G., Biondi M.L., DeMonti M. et al. Independentrisk factor for moderate to severe internal carotid arterystenosis: T786C mutation of endothelial nitric oxide syn-thase gene // Clin. Chem. – 2002. – 48, № 7. – P.989–993.
  8. Golser R., Gorren A.C.F., Mayer B., Schmidt K. Func-tional characterization of Glu298Asp mutant human en-dothelial nitric oxide synthase purified from a yeast ex-pression system // Nitric Oxide. – 2003. – 8. – P.7–14.
  9. 9. Hassan A., Gormley K., O’Sullivan M. et al. Endothelialnitric oxide gene haplotypes and risk of cerebral small-vessel disease // Stroke. – 2004. – 35. – P.654–659.
  10. 10. Hibi K., Ishigami T., Tamura K. et al. Endothelial nitric oxidesynthase gene polymorphism and acute myocardial infarction// Hypertension. – 1998. – 32, № 3. – P.521–526.
  11. Hingorani A.D., Liang C.F., Fatibene J. et al. A commonvariant of the endothelial nitric oxide synthase(Glu298 Asp) is a major risk factor for coronary arterydisease in the UK // Circulation. – 1999. – 100, № 14. –P.1515–1520.
  12. Jayachandran M., Miller V.M. Ovariectomy upregula-tes expression of estrogen receptors, NOS, and HSPsin porcine platelets // Amer. J. Physiol. Heart Circ.Physiol. – 2002. – 283. – H220–H226.
  13. Jeerooburkhan N., Jones L.C., Bujac S. et al. Geneticand environmental determinants of plasma nitrogenoxides and risk of ischemic heart disease // Hyperten-sion. – 2001. – 38. – P.1054–1061.
  14. Nakayama M., Yasue H., Yoshimura M. et al. T-786 CMutation in the 5'-flanking region of the endothelial ni-tric oxide synthase gene is associated with coronaryspasm // Circulation. – 1999. – 99. – P.2864–2870.
  15. Oury C., Toth-Zsamboki E., Vermylen J., HoylaertsM.F. P2X(1)-mediated activation of extracellular sig-nal-regulated kinase 2 contributes to platelet secretionand aggregation induced by collagen // Blood. – 2002. –100, №7. – P.2499–2505.
  16. Ovstebo R., Haug K.B.F., Lande K., Kierulf P. PCR-based calibration curves for studies of quantitative geneexpression in human monocytes: development and evalu-ation // Clin. Chem. – 2003. – 49, №3. – P.425–432.
  17. Randriamboavonjy V., Schrader J., Busse R., Fleming I.Insulin induces the release of vasodilator compounds fromplatelets by a nitric oxide-G kinase-VAMP-3-dependentpathway // J. Exp. Med. – 2004. – 199, №3. – P.347–356.
  18. Song J., Yoon Y., Park K.U. et al. Genotype-specificinfluence on nitric oxide synthase gene expression, pro-tein concentration, and enzyme activity in culturedhuman endothelial cells // Clin. Chem. – 2003. – 49,№ 6. – P.847–852.
  19. 19. Wang J., Dudley D., Wang X.L. Haplotype-specificeffects on endothelial NO synthase promoter effi-ciency: modifiable by cigarette smoking // Arterioscler.Thromb. Vasc. Biol. – 2002. – 22, № 5. – P.1–4.
  20. 20. Wang X.L., Sim A.S., Wang M.X. et al. Genotype de-pendent and cigarette specific effects on endothelialnitric oxide synthase gene expression and enzyme ac-tivity // FEBS Lett. – 2000. – 471, № 1. – P.45–50.
  21. Yoon Y., Song J., Hong S.H., Kim J.Q. Plasma nitricoxide concentrations and nitric oxide synthase genein coronary artery disease // Clin.Chem. – 2000. – 46, №10. – P.1626–1630.
  22. Yoshimura M., Yasue H., Nakayama M. et al. Geneticrisk factors for coronary artery spasm: significance ofendothelial nitric oxide synthase gene T-786 C andmissense Glu298Asp variants // J. Investig. Med. –2000. – 48, № 5. – P.367–374.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.